JUAN MANUEL SALAS PEREGRÍN-rekin lankidetzan egindako argitalpenak (6)

2014

  1. Lanthanide complexes containing 5-methyl-1,2,4-triazolo[1,5-a] pyrimidin-7(4H)-one and their therapeutic potential to fight leishmaniasis and Chagas disease

    Journal of Inorganic Biochemistry, Vol. 138, pp. 39-46

  2. Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis

    European Journal of Medicinal Chemistry, Vol. 85, pp. 526-534

2012

  1. In vitro anti-leishmania evaluation of nickel complexes with a triazolopyrimidine derivative against Leishmania infantum and Leishmania braziliensis

    Journal of Inorganic Biochemistry, Vol. 112, pp. 1-9

  2. Structural consequences of the introduction of 2,2′-bipyrimidine as auxiliary ligand in triazolopyrimidine-based transition metal complexes. in vitro antiparasitic activity

    Polyhedron, Vol. 33, Núm. 1, pp. 137-144

2011

  1. Biological activity of three novel complexes with the ligand 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one against Leishmania spp

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 4, pp. 813-819

  2. In vitro and in vivo antiparasital activity against Trypanosoma cruzi of three novel 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-based complexes

    Journal of Inorganic Biochemistry, Vol. 105, Núm. 6, pp. 770-776